We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
-6.4%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$88M
AUM Growth
-$19.7M
Cap. Flow
-$5.9M
Cap. Flow %
-6.7%
Top 10 Hldgs %
91.84%
Holding
33
New
7
Increased
14
Reduced
5
Closed
2

Top Buys

Rank Stock Value
1
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
+$2.62M
2
AMLP icon
Alerian MLP ETF
AMLP
+$473K
3
ABDC
Alcentra Capital Corp
ABDC
+$320K
4
V icon
Visa
V
+$224K
5
MA icon
Mastercard
MA
+$223K

Top Sells

Rank Stock Value
1
ICMB icon
Investcorp Credit Management BDC
ICMB
+$6.32M
2
LITS
Lite Strategy Inc
LITS
+$3.98M
3
ARQL
Arqule Inc
ARQL
+$700K
4
MRKR icon
Marker Therapeutics
MRKR
+$110K
5
GSM icon
FerroAtlántica
GSM
+$15.2K

Sector Composition

Rank Sector Weight
1 Healthcare 66.39%
2 Financials 3.8%
3 Consumer Discretionary 0.56%
4 Industrials 0.52%
5 Technology 0.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBBP
1
DELISTED
Strongbridge Biopharma plc.
SBBP
$20.7M 23.51%
6,612,065
– –
MTEM
2
DELISTED
Molecular Templates, Inc.
MTEM
$13.6M 15.4%
108,283
– –
KALA icon
3
KALA BIO
KALA
$15.7M
$9.6M 10.9%
602
+1
+0.2% +$16.6K
GARS
4
DELISTED
Garrison Capital Inc.
GARS
$8.44M 9.58%
1,223,096
-2,000
-0.2% -$14K
ABDC
5
DELISTED
Alcentra Capital Corp
ABDC
$7.03M 7.98%
838,840
+38,840
+5% +$320K
SCYX icon
6
SCYNEXIS
SCYX
$44.5M
$5.67M 6.44%
54,063
– –
LITS
7
Lite Strategy Inc
LITS
$33M
$5.25M 5.97%
105,077
-67,879
-39% -$3.98M
AMLP icon
8
Alerian MLP ETF
AMLP
$12.7B
$4.53M 5.14%
91,949
+9,571
+12% +$473K
SPY icon
9
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$4.11M 4.66%
14,010
– –
BRK.B icon
10
Berkshire Hathaway Class B
BRK.B
$1.06T
$1.99M 2.25%
9,312
– –
VIRX
11
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.92M 2.18%
75,595
+67,674
+854% +$2.62M
EIGR
12
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$656K 0.75%
2,063
+420
+26% +$145K
KURA icon
13
Kura Oncology
KURA
$967M
$540K 0.61%
27,402
+8,128
+42% +$135K
MELI icon
14
Mercado Libre
MELI
$94.2B
$280K 0.32%
457
+22
+5% +$12.2K
CTIC
15
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$279K 0.32%
324,452
+1,426
+0.4% +$1.32K
GB
16
DELISTED
Global Blue Group Holding
GB
$260K 0.3%
25,509
+56
+0.2% +$563
DRNA
17
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$244K 0.28%
15,487
-240
-2% -$3.26K
FSK icon
18
FS KKR Capital
FSK
$3.11B
$242K 0.27%
10,137
+22
+0.2% +$541
V icon
19
Visa
V
$694B
$238K 0.27%
+1,370
New +$224K
MA icon
20
Mastercard
MA
$487B
$236K 0.27%
+892
New +$223K
CHTR icon
21
Charter Communications
CHTR
$16.4B
$234K 0.27%
+591
New +$221K
AMT icon
22
American Tower
AMT
$78.7B
$232K 0.26%
1,136
+39
+4% +$7.84K
CACC icon
23
Credit Acceptance
CACC
$6.67B
$232K 0.26%
479
+19
+4% +$9.03K
TDG icon
24
TransDigm Group
TDG
$68.9B
$232K 0.26%
479
+21
+5% +$9.82K
UAL icon
25
United Airlines
UAL
$38.6B
$225K 0.26%
+2,566
New +$217K
1
2

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return

Caxton Corporation's Q2 2019 Portfolio in Review

As of Q2 2019, Caxton Corporation held 33 positions worth $88M, down 18% from $108M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Caxton Corporation withdrew a net $5.9M in Q2 2019, closing 2 positions and reducing 5 holdings. Its most notable exit was Investcorp Credit Management BDC, an estimated $6.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 69% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Caxton Corporation opened a new position in Visa worth $238K.

  • Caxton Corporation's largest Q2 2019 buy was Visa: 1,370 shares worth $238K.
  • Caxton Corporation added most to Viracta Therapeutics, Inc. Common Stock in Q2 2019, an estimated $2.62M increase.
  • Caxton Corporation's biggest Q2 2019 reduction was Lite Strategy Inc, cutting an estimated $3.98M.
  • Caxton Corporation fully exited Investcorp Credit Management BDC in Q2 2019, selling an estimated $6.32M.
  • Caxton Corporation's ten largest holdings make up 92% of its $88M portfolio in Q2 2019.
  • Caxton Corporation opened 7 new positions and closed 2 in Q2 2019.
  • Caxton Corporation's portfolio value fell 18% quarter-over-quarter to $88M.

Based on Caxton Corporation's 13F filing for Q2 2019, filed 14 Aug 2019.